Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Eliem Therapeutics, Inc. (ELYM) had Return on Equity of -32.64% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-35.12M |
|
-- |
|
-- |
|
$40.27M |
|
$-40.27M |
|
$5.16M |
|
$-35.12M |
|
$-35.12M |
|
$-35.12M |
|
$-35.12M |
|
$-35.12M |
|
$-35.12M |
|
$-40.27M |
|
$-42.61M |
|
26.99M |
|
26.99M |
|
$-1.30 |
|
$-1.30 |
|
| Balance Sheet Financials | |
$110.25M |
|
-- |
|
$0.21M |
|
$110.47M |
|
$2.83M |
|
-- |
|
$0.04M |
|
$2.87M |
|
$107.60M |
|
$107.60M |
|
$107.60M |
|
27.70M |
|
| Cash Flow Statement Financials | |
$-20.60M |
|
$68.98M |
|
$0.84M |
|
$43.59M |
|
$93.11M |
|
$49.53M |
|
$12.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
38.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-32.64% |
-32.64% |
|
-31.79% |
|
-32.64% |
|
$3.88 |
|
$-0.76 |
|
$-0.76 |
|